INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 179 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $0 | – | 18 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 18 | -96.1% | 0.00% | – |
| Q3 2020 | $19,000 | -36.7% | 464 | -26.8% | 0.00% | – |
| Q2 2020 | $30,000 | -38.8% | 634 | -19.7% | 0.00% | – |
| Q1 2020 | $49,000 | -27.9% | 790 | +42.1% | 0.00% | – |
| Q4 2019 | $68,000 | +88.9% | 556 | -1.4% | 0.00% | – |
| Q3 2019 | $36,000 | -54.4% | 564 | -42.9% | 0.00% | – |
| Q2 2019 | $79,000 | -24.8% | 987 | +5.2% | 0.00% | – |
| Q1 2019 | $105,000 | +52.2% | 938 | +37.7% | 0.00% | – |
| Q4 2018 | $69,000 | -22.5% | 681 | -2.0% | 0.00% | – |
| Q3 2018 | $89,000 | +48.3% | 695 | -0.4% | 0.00% | – |
| Q2 2018 | $60,000 | +5.3% | 698 | -25.5% | 0.00% | – |
| Q1 2018 | $57,000 | -40.0% | 937 | -42.6% | 0.00% | – |
| Q4 2017 | $95,000 | +25.0% | 1,633 | +24.6% | 0.00% | – |
| Q3 2017 | $76,000 | -74.8% | 1,311 | -47.3% | 0.00% | – |
| Q2 2017 | $302,000 | +31.9% | 2,490 | +23.3% | 0.00% | – |
| Q1 2017 | $229,000 | +5.0% | 2,020 | +0.7% | 0.00% | – |
| Q4 2016 | $218,000 | +581.2% | 2,006 | +903.0% | 0.00% | – |
| Q3 2016 | $32,000 | -23.8% | 200 | -33.3% | 0.00% | – |
| Q2 2016 | $42,000 | +250.0% | 300 | +200.0% | 0.00% | – |
| Q1 2016 | $12,000 | +50.0% | 100 | +100.0% | 0.00% | – |
| Q4 2015 | $8,000 | -50.0% | 50 | -50.0% | 0.00% | – |
| Q3 2015 | $16,000 | -94.8% | 100 | -92.2% | 0.00% | – |
| Q2 2015 | $308,000 | +214.3% | 1,280 | +265.7% | 0.00% | – |
| Q1 2015 | $98,000 | +880.0% | 350 | +483.3% | 0.00% | – |
| Q4 2014 | $10,000 | -65.5% | 60 | -51.2% | 0.00% | – |
| Q3 2014 | $29,000 | -84.7% | 123 | -84.7% | 0.00% | – |
| Q2 2014 | $189,000 | +8.6% | 802 | +52.2% | 0.00% | – |
| Q1 2014 | $174,000 | – | 527 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 234,375 | $23,623,000 | 22.67% |
| Boxer Capital, LLC | 600,000 | $60,474,000 | 7.47% |
| DLD Asset Management, LP | 834,600 | $84,136,000 | 5.77% |
| GREAT POINT PARTNERS LLC | 200,000 | $20,158,000 | 2.55% |
| BB BIOTECH AG | 575,719 | $58,027,000 | 1.86% |
| Elk Creek Partners, LLC | 207,657 | $20,930,000 | 1.74% |
| ALTRINSIC GLOBAL ADVISORS LLC | 277,944 | $28,014,000 | 1.34% |
| Sarissa Capital Management LP | 54,000 | $5,442,000 | 1.21% |
| QCM Cayman, Ltd. | 2,181 | $220,000 | 0.90% |
| Opus Point Partners Management, LLC | 3,534 | $356,000 | 0.78% |